Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Lin, Been Ren ^a   Huang, Miao Tzu ^a   Chen, Szu Ta ^a   Jeng, Yung Ming ^a   Li, Yue Ju ^b   Liang, Jin Tung ^a   Lee, Po Huang ^a   Chang, King Jen ^a,c   Chang, Cheng Chi ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE INHIBITOR; CYTOKINE; MESSENGER RNA; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROL GROUP; FEMALE; GENOME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PLASMID; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PLASMIDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 84865003622     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1825-x     Document Type: Article

References (41)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
2. BR Lin CC Chang TF Che ST Chen RJ Chen CY Yang, et al. 2005 Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer Gastroenterology. 128 9 23 15633118 10.1053/j.gastro.2004.10.007 1:CAS:528:DC%2BD2MXhtFahtrY%3D
3. S Manfredi AM Bouvier C Lepage C Hatem V Dancourt J Faivre 2006 Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population Br J Surg. 93 1115 1122 16804870 10.1002/bjs.5349 1:STN:280:DC%2BD28rhs1Wmug%3D%3D
4. LC Burkly JS Michaelson K Hahm A Jakubowski TS Zheng 2007 TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease Cytokine. 40 1 16 17981048 10.1016/j.cyto.2007.09.007 1:CAS:528:DC%2BD2sXhtlajtrzL
5. JA Winkles 2008 The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat Rev Drug Discov. 7 411 425 18404150 10.1038/nrd2488 1:CAS:528:DC%2BD1cXlt1agtb0%3D
6. Y Chicheportiche PR Bourdon H Xu YM Hsu H Scott C Hession, et al. 1997 TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem. 272 32401 32410 9405449 10.1074/jbc.272.51.32401 1:CAS:528:DyaK1cXis1Ojug%3D%3D
7. A Jakubowski C Ambrose M Parr JM Lincecum MZ Wang TS Zheng, et al. 2005 TWEAK induces liver progenitor cell proliferation J Clin Invest. 115 2330 2340 16110324 10.1172/JCI23486 1:CAS:528:DC%2BD2MXhtVSjsrbL
8. C Dogra H Changotra S Mohan A Kumar 2006 Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein J Biol Chem. 281 10327 10336 16461349 10.1074/jbc.M511131200 1:CAS:528:DC%2BD28Xjt1Kns7w%3D
9. G Tiller P Fischer-Posovszky H Laumen A Finck T Skurk M Keuper, et al. 2009 Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes Endocrinology. 150 5373 5383 19887572 10.1210/en.2009-0488 1:CAS:528: DC%2BD1MXhsFGqtbzE
10. SJ Perper B Browning LC Burkly S Weng C Gao K Giza, et al. 2006 TWEAK is a novel arthritogenic mediator J Immunol. 177 2610 2620 16888023 1:CAS:528:DC%2BD28Xns1Kgs78%3D
11. RL Meighan-Mantha DK Hsu Y Guo SA Brown SL Feng KA Peifley, et al. 1999 The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration J Biol Chem. 274 33166 33176 10551889 10.1074/jbc.274.46.33166 1:CAS:528:DyaK1MXntlynsrk%3D
12. JS Michaelson LC Burkly 2009 Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway Results Probl Cell Differ. 49 145 160 19513634 10.1007/400-2008-18 1:CAS:528:DC%2BC3cXhs1emsrjP
13. JA Winkles NL Tran SA Brown N Stains HE Cunliffe ME Berens 2007 Role of TWEAK and Fn14 in tumor biology Front Biosci. 12 2761 2771 17127278 10.2741/2270 1:CAS:528:DC%2BD28Xht1Ontr7P
14. AF Chambers AC Groom IC MacDonald 2002 Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer. 2 563 572 12154349 10.1038/nrc865 1:CAS:528:DC%2BD38XlslGqsLw%3D
15. PS Steeg 2006 Tumor metastasis: mechanistic insights and clinical challenges Nat Med. 12 895 904 16892035 10.1038/nm1469 1:CAS:528: DC%2BD28Xnsl2iu74%3D
16. K Yeung T Seitz S Li P Janosch B McFerran C Kaiser, et al. 1999 Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP Nature. 401 173 177 10490027 10.1038/43686 1:CAS:528:DyaK1MXlvFKgsLk%3D
17. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst. 96 1420 1425 15467030 10.1093/jnci/djh275
18. SA Marsters JP Sheridan RM Pitti J Brush A Goddard A Ashkenazi 1998 Identification of a ligand for the death-domain-containing receptor Apo3 Curr Biol. 8 525 528 9560343 10.1016/S0960-9822(98)70204-0 1:CAS:528: DyaK1cXislaksbg%3D
19. FO Baxter PJ Came K Abell B Kedjouar M Huth K Rajewsky, et al. 2006 IKKβ/2 induces TWEAK and apoptosis in mammary epithelial cells Development. 133 3385 3394 10.1242/dev.02502
20. A De JI Park K Kawamura R Chen C Klein R Rauch, et al. 2006 Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization Mol Endocrinol. 20 2528 2538 16762976 10.1210/me.2006-0028 1:CAS:528:DC%2BD28XhtVOht7nO
21. MR Chacon C Richart JM Gómez A Megía N Vilarrasa JM Fernández-Real, et al. 2006 Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity Cytokine. 33 129 137 16503147 10.1016/j.cyto.2005.12.005 1:CAS:528:DC%2BD28Xit1Cmsbs%3D
22. DH Ho H Vu SA Brown PJ Donohue HN Hanscom JA Winkles 2004 Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice Cancer Res. 64 8968 8972 15604260 10.1158/0008-5472.CAN-04-1879 1:CAS:528:DC%2BD2cXhtVOmsLrF
23. H Zhao A Langerod Y Ji KW Nowels JM Nesland R Tibshirani, et al. 2004 Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol Biol Cell. 15 2523 2536 15034139 10.1091/mbc.E03-11-0786 1:CAS:528:DC%2BD2cXks1yrs7c%3D
24. T Kawakita K Shiraki Y Yamanaka Y Yamaguchi Y Saitou N Enokimura, et al. 2004 Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis Biochem Biophys Res Commun. 318 726 733 15144899 10.1016/j.bbrc.2004.04.084 1:CAS:528: DC%2BD2cXktV2mtr0%3D
25. NL Tran WS McDonough PJ Donohue JA Winkles TJ Berens KR Ross, et al. 2003 The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors Am. J. Pathol. 162 1313 1321 12651623 10.1016/S0002-9440(10)63927-2 1:CAS:528:DC%2BD3sXjtVemtbs%3D
26. T Kawakita K Shiraki Y Yamanaka Y Yamaguchi Y Saitou N Enokimura, et al. 2005 Functional expression of TWEAK in human colonic adenocarcinoma cells Int J Oncol. 26 87 93 15586228 1:CAS:528:DC%2BD2MXmsFWisw%3D%3D
27. D Wang JN Fung Y Tuo L Hu C Chen 2010 TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway Cancer Lett. 294 91 100 20189297 10.1016/j.canlet.2010.01.027 1:CAS:528:DC%2BC3cXmtlyitbY%3D
28. S Dionne E Levy D Levesque EG Seidman 2010 PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis Anticancer Res. 30 157 166 20150631 1:CAS:528: DC%2BC3cXjtVymurg%3D
29. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, et al. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol. 2003;170:341-8.
30. NL Tran WS McDonough BA Savitch SP Fortin JA Winkles M Symons, et al. 2006 Increased fibroblast growth factor-inducible 14ex pression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome Cancer Res. 66 9535 9542 17018610 10.1158/0008-5472.CAN-06- 0418 1:CAS:528:DC%2BD28XhtVamsrfK
31. SP Fortin MJ Ennis BA Savitch D Carpentieri WS McDonough JA Winkles, et al. 2009 Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function Mol Cancer Res. 7 1871 1881 19861406 10.1158/1541-7786.MCR-09-0194 1:CAS:528:DC%2BD1MXhsVamsr3M
32. L Dai L Gu C Ding L Qiu W Di 2009 TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression Cancer Lett. 283 159 167 19398263 10.1016/j.canlet.2009.03.036 1:CAS:528:DC%2BD1MXptlanur0%3D
33. CN Lynch YC Wang JK Lund YW Chen JA Leal SR Wiley 1999 TWEAK induces angiogenesis and proliferation of endothelial cells J Biol Chem. 274 8455 8459 10085077 10.1074/jbc.274.13.8455 1:CAS:528:DyaK1MXitFyrs7o%3D
34. SR Wiley L Cassiano T Lofton T Davis-Smith JA Winkles V Lindner, et al. 2001 A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis Immunity. 15 837 846 11728344 10.1016/S1074-7613(01)00232-1 1:CAS:528:DC%2BD3MXptVGgtbY%3D
35. KC Yeung DW Rose AS Dhillon D Yaros M Gustafsson D Chatterjee, et al. 2001 Raf kinase inhibitor protein interacts with NF-kappaBinducing kinase and TAK1 and inhibits NF-kappaB activation Mol Cell Biol. 21 7207 7217 11585904 10.1128/MCB.21.21.7207-7217.2001 1:CAS:528:DC%2BD3MXns1Wjtrc%3D
36. D Chatterjee Y Bai Z Wang S Beach S Mott R Roy, et al. 2004 RKIP sensitizes prostate and breast cancer cells to drug induced apoptosis J Biol Chem. 279 17515 17523 14766752 10.1074/jbc.M313816200 1:CAS:528: DC%2BD2cXjt1Gnt7Y%3D
37. Z Fu PC Smith L Zhang MA Rubin RL Dunn Z Yao, et al. 2003 Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis J Natl Cancer Inst. 95 878 889 12813171 10.1093/jnci/95.12.878 1:CAS:528:DC%2BD3sXkvVSmtL8%3D
38. MM Schuierer F Bataille S Hagan W Kolch AK Bosserhoff 2004 Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal regulated kinase signaling in melanoma cell lines Cancer Res. 64 5186 5192 15289323 10.1158/0008-5472.CAN-03-3861 1:CAS:528:DC%2BD2cXmtF2mtLc%3D
39. F Al-Mulla S Hagan AI Behbehani MS Bitar SS George JJ Going, et al. 2006 Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients J Clin Oncol. 24 5672 5679 17179102 10.1200/JCO.2006.07.5499 1:CAS:528:DC%2BD2sXhtVChs7o%3D
40. H Prenen S Tejpar E Van Cutsem 2010 New strategies for treatment of KRAS mutant metastatic colorectal cancer Clin Cancer Res. 16 2921 2926 20460490 10.1158/1078-0432.CCR-09-2029 1:CAS:528:DC%2BC3cXms1Ojs70%3D
41. S Benvenuti A Sartore-Bianchi F Di Nicolantonio C Zanon M Moroni S Veronese, et al. 2007 Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies Cancer Res. 67 2643 2648 17363584 10.1158/0008-5472.CAN-06-4158 1:CAS:528:DC%2BD2sXivV2ns7w%3D